AbbVie and Sosei agreed to cooperate in the field of drug development

Company AbbVie and Sosei concluded an agreement on joint development of drugs, the cost of which may reach $ 1 billion, writes Reuters.

The parties will work together to conduct research and commercialize drugs specific to the receptors associated with G-protein (GPCR). As a down payment to Sosei will receive $ 32 million, together with subsequent payments and royalties from sales total amount of payments could reach $ 1 billion. AbbVie will also have the opportunity to expand cooperation and development of the four candidate drugs.

The development of similar drugs with Sosei cooperate with Genentech, and Takeda.

Leave a Reply

Your email address will not be published. Required fields are marked *


AbbVie and Genmab will co-operate in the development of anticancer drugs

Company AbbVie and Genmab announced the signing of an agreement on cooperation in the development and marketing of three experimental drugs based on antibodies bispecific are working professionals Genmab. Under the agreement, AbbVie will pay Genmab 750 million dollars as an advance, the total amount of payments in the long term can be up to […]

Pharmaceutical companies sent $ 1 billion for the development of antibiotics

International Federation of pharmaceutical manufacturers and associations has launched a new Fund to Finance the development of antibacterial drugs. The largest pharmaceutical companies in the world have already sent to the Fund of $ 1 billion, according to Reuters. The development of new antibiotics plays a key role in the fight against antibiotic resistance, however, […]

In Russia confirmed 6 635 new cases of coronavirus

In recent days in Russia diagnosed 6 635 new cases of coronavirus infection in 85 regions. In 25,2% of patients there are no clinical manifestations of the disease. Day 174 people died, fully recovered 7 752 of the patient. In Moscow revealed 637 new case, it’s more than the day before. In second place on […]